Torben Harsløf - Concepedia

Author

Torben Harsløf

Aarhus University Hospital ORCID

Also Known As

Harsløf T, Harsløf, Torben, T Harsløf, T. Harsløf, T. Harsløf⁎, Torben Harslof, Torben Harsløf

116

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Aarhus University Odense University Hospital University of Southern Denmark Hvidovre Hospital

About

Torben Harsløf is an author at Aarhus University Hospital specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	783
2	Health Sciences	4	4	158
3	Public Health	2	2	77
4	Engineering	1	1	23
5	Natural Sciences	1	1	22

Torben Harsløf

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Resveratrol Increases Bone Mineral Density and Bone Alkaline Phosphatase in Obese Men: A Randomized Placebo-Controlled Trial Marie Juul Ørnstrup, Torben Harsløf, Thomas Kjær, The Journal of Clinical Endocrinology & Metabolism	2014	139
A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk Signe S. Torekov, Torben Harsløf, Lars Rejnmark, The Journal of Clinical Endocrinology & Metabolism	2014	104
Treatment with Zoledronate Subsequent to Denosumab in Osteoporosis: a Randomized Trial Anne Sophie Sølling, Torben Harsløf, Bente Langdahl Journal of Bone and Mineral Research	2020	100
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study Anne Sophie Sølling, Torben Harsløf, Bente Langdahl Journal of Bone and Mineral Research Bone DiseaseBone HealthZoledronate SubsequentZol 6Initial Zol	2020	98
Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial Katrine Hygum, Torben Harsløf, Niklas Rye Jørgensen, Bone Bone DiseaseBone HealthBone ResorptionDiabetesType 2	2019	69
Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures Alexander Egeberg, Peter Schwarz, Torben Harsløf, JAMA Dermatology	2021	66
Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective Louise Hansen, Karin Dam Petersen, Stine Aistrup Eriksen, Osteoporosis International Skeletal TraumaSubsequent Fracture RatesBone HealthFracture DiagnosticsFracture Healing	2014	61
Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women Sofie Hertz Rønn, Torben Harsløf, Steen B. Pedersen, European Journal of Endocrinology	2016	60
Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis Lise B. Husted, Torben Harsløf, L. Stenkjær, Osteoporosis International SclerostinBone Morphogenic ProteinMedicineGeneticsPathology	2012	56
Rosiglitazone Decreases Bone Mass and Bone Marrow Fat Torben Harsløf, Louise Wamberg, Louise Møller, The Journal of Clinical Endocrinology & Metabolism	2011	55

Page 1